Peter Ginsberg is Vice President of Business Development at Savara Pharmaceuticals (SVRA), an orphan lung disease company. Previously, he headed business development for BioDelivery Sciences (BDSI), SurModics (SRDX) and United Therapeutics (UTHR), a former resident of First Flight Venture Center. Ginsberg also served as VP of Business & Technology Development for the North Carolina Biotechnology Center, where his group financed and advised emerging life science companies. He also spent 15 years in the healthcare investment industry, during which time he was named a Wall Street Journal All-Star as Piper Jaffray’s lead biotechnology analyst.
Ginsberg acts as a reviewer/mentor for the National Heart, Lung, and Blood Institute and is also a Chartered Financial Analyst and member of the CFA Institute. He earned an A.B. in Economics from Princeton University and an M.B.A. from the Tuck School of Business at Dartmouth College.